Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This study was designed to evaluate the safety and efficacy of Cesamet™ in controlling pain
in subjects experiencing pain due to chemotherapy-induced neuropathic pain in patients with
cancer.